SLC6A3 and attention deficit-hyperactivity disorder: In 2017, Ding and colleagues demonstrated that the methylation profile in the DAT1 gene is modulated in response to methylphenidate (MPH) treatment, along with its efficacy on hyperactive–impulsive symptoms in ADHD [9].